Discontinued — last reported Q3 '18
Veeva Systems Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) remained flat by 0.0% to $5.83M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 25.1%, from $7.78M to $5.83M. This is a positive signal — lower values indicate better performance for this metric.
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1| Q1 '21 | Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.17M | $13.31M | $13.31M | $8.92M | $8.92M | $8.92M | $7.78M | $7.78M | $7.78M | $7.78M | $7.78M | $7.78M | $5.83M | $5.83M | $5.83M |
| QoQ Change | — | +1.1% | +0.0% | -33.0% | +0.0% | +0.0% | -12.8% | +0.0% | +0.0% | +0.1% | +0.0% | +0.0% | -25.1% | +0.0% | +0.0% |
| YoY Change | — | — | — | -32.2% | -33.0% | -33.0% | -12.8% | -12.8% | -12.8% | +0.1% | +0.1% | +0.1% | -25.1% | -25.1% | -25.1% |